Microsynth

1. Executive Summary (Confidence: High)

Since its founding in 1989 by Dr. Tobias Schmidheini, Microsynth AG has grown from a specialized "garage startup" into an essential pillar of the European life sciences infrastructure. Headquartered in Balgach, Switzerland, the company operates across three primary business areas: DNA/RNA synthesis, DNA/RNA analysis (including Sanger and Next-Generation Sequencing), and contract research/outsourcing. With a workforce of over 130 and subsidiaries in Germany, Austria, and France, Microsynth supports the longevity ecosystem by providing high-quality genomic tools required for the development of cell, gene, and mRNA therapies. The organization is distinguished by its deep technical expertise and its commitment to quality, holding numerous ISO and Swissmedic GMP certifications that enable it to serve the most regulated sectors of the pharmaceutical industry.